BA — The Boeing Company

Sentiment is genuinely split, which is why Neutral is the honest read rather than Bullish or Bearish. The tape is skeptical: BA fell 8.97% in the month into 2026-09-13, printed a death cross (50-day below 200-day), and sits 1.27%/3.78%/4.66% below its 20/50/200-day averages. The proximate cause is operational - August 2026 deliveries slipped to 51 from 53 in July and 57 in August 2025, with only four 787 Dreamliners handed over, so the widebody ramp that carries the margin story visibly wobbled. The sell-side is far more constructive: 38 buy ratings versus 5 sells, a $274.29 consensus price target (~30% above the 2026-09-13 price of $210.45), 418 aircraft delivered YTD, a 6,755-aircraft unfilled backlog, FAA clearance to raise 737 MAX output from 42 to 47/month, and a revised four-year SPEEA contract with an immediate 10% raise that the union's bargaining committee recommended for approval in mid-September 2026. Investors are arguing about timing, not direction.

The three-year series shows a deep trough and a real, but still thin, inflection. Revenue bottomed at $15.24B in Q4 2024 (the strike quarter) and has climbed every quarter since: $19.50B (Q1'25), $22.75B (Q2'25), $23.27B (Q3'25), $23.95B (Q4'25), $22.22B (Q1'26), and a record $24.56B in Q2'26. Year-over-year revenue growth is, however, decelerating sharply as the depressed base rolls off: +57% in Q4'25, +30% in Q3'25, +14% in Q1'26, +8% in Q2'26. That is arithmetic normalization, not deterioration - but it does mean the headline growth optics get worse from here regardless of execution. Profitability is the real story: operating income went from -$5.76B (Q3'24) and -$3.82B (Q4'24) and -$4.79B (Q3'25, a large charge quarter) to -$0.82B (Q4'25), then +$448M (Q1'26) and +$78M (Q2'26). Gross margin swung from -10.2% in Q3'25 to +9.8% in Q2'26. But GAAP net income is still negative (-$4M in Q1'26, -$444M in Q2'26), and the huge +$8.22B net income in Q4'25 was a non-operating artifact - the quarter simultaneously posted a -$815M operating loss - so trailing EPS of $3.08 and the 78.8x P/E built on it are close to meaningless. Free cash flow tells the same inflection story: 2024 burned roughly $14.3B across the four quarters, 2025 burned about $3.2B, and H1 2026 burned $823M (-$1.454B in Q1, +$631M in Q2) - a $1.67B year-over-year improvement with the first genuinely clean positive FCF quarter in the dataset. Verdict: genuine inflection off a cyclical/safety trough, not structural decline, but the level of profitability is still far too low for a $166B market cap.

On trailing metrics Boeing looks expensive on almost every line, though the comparatives are distorted. As of 2026-09-13: P/E TTM 78.82 on EPS of $3.078 (itself inflated by a non-cash Q4 2025 tax benefit), P/B 27.29 on $6.1B of equity, EV/EBITDA 29.5x, debt/equity 7.52x, and a TTM operating margin of -5.4%. The only metric that argues 'cheap' is price-to-sales: 1.77x versus a 5-year average of 1.84x, and the 5-year average P/E of 87.2x (computed on just one usable year, so treat it as noise) versus 78.8x today. There is effectively no forward P/E to quote: consensus for the next fiscal year is revenue of ~$98.1B with EPS of -$0.997, i.e. analysts still do not model GAAP profitability in the forward year. PEG of 0.422 is not useful given the negative/distorted earnings base. The deterministic score labels this 'Neutral vs. its own history,' which matches my read: not a bargain, not a bubble - the market is paying roughly fair-to-full value for a recovery it can see but that has not yet arrived in the reported numbers.

The central tension is that at $210.45 (2026-09-13) the market is capitalizing earnings that do not exist yet. H1 2026 GAAP net loss was $448M; the stock still trades at 78.8x trailing EPS of $3.08 and 29.5x EV/EBITDA. That only makes sense if you believe 2028 earnings power looks radically different - roughly $110B of revenue at a 9% operating margin generates about $7.90 of normalized EPS, which at ~26x is roughly today's price. So the market is not obviously mispricing the recovery; it is pricing it at a fair multiple with no cushion. Practical implication: this is a 'prove it' name. Each quarter that shows operating margin expansion and positive FCF supports the multiple; each quarter with a widebody delivery miss (four 787s in August) or a new charge compresses it, because there is no trailing earnings floor underneath. Buyers here are underwriting 2027-2028 execution, not 2026 earnings.

As of 2026-09-13 the technical setup was weak but not washed out. RSI-14 stood at 44.91 - neutral, neither oversold nor overbought, meaning no mechanical bounce signal. Price was 1.27% below the 20-day SMA, 3.78% below the 50-day and 4.66% below the 200-day, with a death cross in place, and the stock sits in the lower-middle of its 52-week range of $176.77-$254.35. Returns: -8.97% over one month, -3.93% over three months, +0.27% over six months, -0.85% over one week - a rolling-over pattern, not a base. Reference levels worth watching: support near $205.50, resistance around $241; reclaiming the 50-day and then $241 is the minimum confirmation that the drift has stopped. Entry-timing implication: there is no technical urgency to buy here, and RSI at 44.9 leaves room for further downside before the oversold zone (sub-30) is reached. The 52-week low at $176.77 is the level where the risk/reward genuinely shifts.

• Interest rates and airline capex: high financing costs pressure airline fleet-expansion budgets, and while resilient passenger demand has kept cancellations low, the 6,755-aircraft backlog converts to deliveries only if customers can fund them; any easing in rates is a direct tailwind.
• FAA and regulatory oversight: the 737 MAX rate increase from 42 to 47/month was only permitted after meeting regulatory requirements, and the 737-10 and 777X certification timelines are entirely gated by regulator/quality audit sign-off - execution risk is as much regulatory as industrial.
• Supply chain and sub-tier constraints: component bottlenecks have eased but remain uneven, and the August 2026 widebody shortfall (just four 787s delivered) shows how one sub-tier or interior-fit issue can distort a month and the quarterly cash flow that follows.
• Labor relations: the SPEEA engineering contract (four years, immediate 10% raise, bargaining committee recommending approval in September 2026) removes a near-term disruption risk but adds to a cost base that is already producing a TTM operating margin of -5.4%.
• Defense spending and geopolitics: BDS revenue depends on U.S. and allied defense budgets, and Boeing's fixed-price development programs have repeatedly produced large forward-loss charges - a structural drag that is sensitive to program timing rather than to the macro cycle.
• Trade/China exposure: a meaningful share of the commercial backlog depends on Chinese order resumption and export-license stability, which is a policy variable rather than a fundamentals variable.

• Q3 2026 earnings (expected late October 2026): the critical test is whether Q2's positive FCF (+$631M) and near-breakeven operating income (+$78M) were the start of a trend, plus management's commentary on the 90-100 unit full-year 787 delivery target.
• Monthly order and delivery reports: 737 line stability toward 47/month, and whether the 787 widebody cadence recovers after only four deliveries in August 2026 (versus 51 total aircraft for the month).
• SPEEA contract vote finalization in September 2026: approval removes near-term labor disruption risk and de-risks the production ramp; rejection reopens a cost and schedule problem.
• 737-10 and 777X certification milestones: successful certification unlocks incremental order conversion and the associated advance payments that fund working capital.
• Potential macro rate relief: cheaper airline financing would support order conversion and potentially restore Chinese order flow, both of which accelerate the backlog-to-cash timeline.

• Balance sheet leverage: $41.35B of long-term debt against just $6.1B of shareholders' equity (debt/equity 7.52x), $7.24B of cash, a 1.14 current ratio and a 0.33 quick ratio. Quarterly operating income of $78M does not cover ~$550M/quarter of interest expense - the company is currently relying on cash balances and improving operating cash flow, not earnings, to service debt.
• Execution risk on the production ramp: the entire bull case rests on 737 MAX moving to 47/month and higher, and on 787 widebody cadence recovering - August 2026's four 787 deliveries is direct evidence of how fragile that is.
• No valuation cushion: at 29.5x EV/EBITDA and 27.3x book with H1 2026 GAAP net loss of $448M, any margin disappointment has no earnings floor to catch the stock; the downside is a multiple reset, not just an estimate cut.
• Recurring program charges: BDS fixed-price development programs and the commercial cost base have produced enormous one-off losses (-$4.79B operating loss in Q3'25, -$5.76B in Q3'24); another charge event would push out the profitability timeline and further strain the thin equity base.
• Safety/quality event risk: after the historical safety crises, FAA oversight remains rigorous and any new quality or safety incident would simultaneously halt the rate ramp, freeze orders and trigger a governance discount that the current multiple does not embed.
• Technical and momentum risk: a death cross with RSI at 44.9 and the stock below all major moving averages means trend-following flows are net sellers until $241 is reclaimed.

Boeing is a real multi-year recovery story, not a value trap - Q2 2026 delivered record revenue of $24.56B, its first positive operating income (+$78M) and positive free cash flow (+$631M) in this dataset, against a 6,755-aircraft backlog that will take roughly a decade to deliver. But at $210.45 as of 2026-09-13 you are paying 29.5x EV/EBITDA and 27.3x book for a company that lost $448M in H1 2026, carries $41.35B of long-term debt against $6.1B of equity, and cannot yet cover its interest expense from operations. My normalized math puts fair value near $205, so the recovery is already broadly in the price, and the deteriorating technicals (death cross, RSI 44.9, -8.97% in a month) mean entry timing is poor. This is a hold/average-in-on-weakness name, not a buy at this level; I would want either a pullback toward the low-$180s or two more quarters of margin and FCF confirmation before underwriting the ramp.

Normalized earnings-power approach: I modeled 2028E revenue of ~$110B (versus ~$94B TTM, and a 2018 peak of ~$101B) at a 9.0% operating margin - between management's long-stated 10% ambition and what the current ~0% operating margin trajectory has actually delivered - giving ~$9.9B of EBIT; subtracting ~$1.9B of net interest on the ~$41-45B debt stack, taxing at 20% and dividing by ~805M diluted shares produces roughly $7.90 of normalized mid-cycle EPS. Applying ~26x - a premium to the S&P justified by the commercial duopoly, the 6,755-aircraft backlog and the BGS aftermarket mix, but well below where BA capitalized peak-cycle earnings - yields ~$205, essentially at the 2026-09-13 price of $210.45. Sensitivity: a 10% margin on $115B of revenue with a 28x multiple gets you to ~$240-250 (roughly the bull/analyst case), while an 8% margin on $105B at 24x gets you to ~$155.